TELO2, a cofactor of phosphatidylinositol 3-kinase-related kinases, has been reported to bind to RICTOR as the mTORC2 complex and promote CRC cell progression through the AKT pathway [44]. The gene discussed is RICTOR; the disease is colorectal carcinoma.